Viatris has lagged the broader Nasdaq Composite over the past year, and Wall Street sentiment toward the stock remains ...

Viatris faces declining sales and debt concerns, but a 2026 recovery may boost earnings. Read about the key risks and future ...

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), formed from the 2020 merger of Mylan ...

Investing.com -- Deutsche Bank struck a more upbeat tone on European pharmaceuticals, upgrading Alvotech to Buy from Hold while keeping its price target at $14. Shares in Alvotech rose 4.6% in U.S.

Greenlight Capital's 13F portfolio rose to $2.33B in Q2 2025. Check out the key new stakes and major increases in the ...